ySBGN - Bidirectional translation between GraphML (yEd Graph Editor) and SBGN-ML
The aim is to provide the most accurate translation for metabolic networks between GraphML (yEd) and SBGN-ML Process Description file formats. Translation in both direction is possible. This project should ultimately be integrated into the SBFC.
- SBGN-ML 0.2 (Process Description)
- yEd 3.17.1
To find more information, please check the Wiki. A brief comparison of the tools we used to edit biological diagrams in the SBGN Process Description language is available in the Editors page. The translation mapping rules are briefly described in Translation page. The latest release including executable application and source files can be directly downloaded from the Releases page.
- Java 8 (with JavaFX if you want to use the GUI)
- Maven (tested with Maven 3.5)
After cloning the repository and getting into its directory:
A small GUI is also provided as the main class of the package. It can be launched by double clicking on the jar or by directly calling the package with
java -jar. Be sure to have JavaFX working in your Java distribution.
The executable jar can be directly downloaded from the Release page.
How to contribute
If you have any suggestions or want to report a bug, don't hesitate to create an issue. Pull requests and all forms of contribution will be warmly welcomed.
Irina Balaur, EISBM, Lyon, France - specified the translation rules, developed the code and the GUI
Alexander Mazein, EISBM, Lyon, France - idea, advice on the translation rules, project coordination
Ludovic Roy, EISBM, Lyon, France - advised on the SBGN-ML format
Vasundra Touré, NTNU, Trondheim, Norway - advised on specific issues
Charles Auffray, EISBM, Lyon, France - strategic advice
- SBGN Bricks
- yEd Graph Editor
- Newt Editor
- CD2SBGMML - translation between CellDesigner and SBGN-ML in both directions
- Disease Maps Project
This work has been supported by the Innovative Medicines Initiative Joint Undertaking under grant agreement no. IMI 115446 (eTRIKS), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.